Montilain-L Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg), indicated for the treatment of chronic spontaneous urticaria, allergic rhinitis, and asthma. It is a dual-action medication that provides rapid and sustained relief from symptoms such as itching, hives, and swelling. Levocetirizine, a histamine-1 receptor antagonist, blocks the action of histamine on H1 receptors, thereby reducing symptoms of allergic reactions. Montelukast, a leukotriene receptor antagonist, inhibits the action of cysteinyl leukotrienes, which are potent mediators of bronchoconstriction and inflammation. By combining these two agents, Montilain-L Tablet offers comprehensive relief from allergic symptoms, including nasal congestion, sneezing, and cough. The medication is available in tablet form and should be taken once daily. It is contraindicated in patients with hypersensitivity to any of its components or with active tuberculosis. As with any medication, patients should consult a healthcare provider before taking Montilain-L Tablet, especially if they have a history of liver disease, kidney disease, or are taking other medications.